Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms
Xin Chen(Guangzhou Medical University), Jinbao Liu(State Key Laboratory of Respiratory Disease)
Cited by 80
Related Papers
Iron Metabolism in Ferroptosis
|Frontiers in Cell and Developmental Biology|2020|940
Copper metabolism in cell death and autophagy
|Autophagy|2023|609
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
|Oncotarget|2014|170
Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
|Cell Death and Disease|2017|118
Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
|Cell Death and Disease|2017|97